lifestyle.travelshq.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Revolution Medicines, Inc.
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
February 25, 2026
Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference
February 24, 2026
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026
February 18, 2026
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026
February 10, 2026
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor
January 29, 2026
←
Previous Page
1
2